Meitav Investment House’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-451
| Closed | -$239K | – | 345 |
|
|
2023
Q4 | $239K | Sell |
451
-71,869
| -99% | -$38.1M | ﹤0.01% | 311 |
|
|
2023
Q3 | $36.7M | Sell |
72,320
-1,007
| -1% | -$510K | 0.59% | 55 |
|
|
2023
Q2 | $37.8M | Sell |
73,327
-1,963
| -3% | -$1.01M | 0.61% | 49 |
|
|
2023
Q1 | $42.4M | Buy |
75,290
+1,665
| +2% | +$937K | 0.73% | 43 |
|
|
2022
Q4 | $41.1M | Sell |
73,625
-6
| -0% | -$3.35K | 0.71% | 41 |
|
|
2022
Q3 | $38M | Buy |
73,631
+25,518
| +53% | +$13.2M | 0.67% | 45 |
|
|
2022
Q2 | $25.9M | Sell |
48,113
-535
| -1% | -$288K | 0.44% | 55 |
|
|
2022
Q1 | $28.5M | Buy |
48,648
+40,254
| +480% | +$23.6M | 0.42% | 58 |
|
|
2021
Q4 | $5.58M | Sell |
8,394
-47,042
| -85% | -$31.2M | 0.09% | 155 |
|
|
2021
Q3 | $31.7M | Buy |
55,436
+10,983
| +25% | +$6.28M | 0.52% | 60 |
|
|
2021
Q2 | $22.4M | Buy |
44,453
+131
| +0.3% | +$66.1K | 0.57% | 53 |
|
|
2021
Q1 | $20.2K | Buy |
44,322
+1,729
| +4% | +$789 | 0.57% | 55 |
|
|
2020
Q4 | $19.8M | Sell |
42,593
-16,827
| -28% | -$7.84M | 0.78% | 54 |
|
|
2020
Q3 | $26.2M | Buy |
59,420
+1,281
| +2% | +$565K | 1.3% | 26 |
|
|
2020
Q2 | $21.1M | Buy |
58,139
+8,672
| +18% | +$3.14M | 1.26% | 24 |
|
|
2020
Q1 | $14M | Buy |
+49,467
| New | +$14M | 1.05% | 34 |
|